CINCINNATI, July 18 /PRNewswire-FirstCall/ -- Kendle will conduct a telephone conference call and simultaneous Webcast Aug. 1 at 8:30 a.m. Eastern Time to discuss its financial results for the Second Quarter 2007. Kendle intends to revise its earnings guidance for fiscal 2007 during the conference call and is withdrawing its previously issued earnings guidance at this time. A question and answer session will follow management’s remarks.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
Webcast Instructions
To access the live Webcast, go to http://www.kendle.com or http://www.videonewswire.com/event.asp?id=40962. Instructions for accessing the Webcast are provided at both sites. The Webcast will be archived at http://www.kendle.com (click on “Investors”) shortly after the call for on- demand replay through 5 p.m. Eastern Time on Aug. 31, 2007. Please note that Webcast participants will not be able to ask questions.
System requirements for the Webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.
To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on Aug. 31 by dialing (706) 645-9291 and entering conference ID number 5447238.
About Kendle
Kendle International Inc. is among the world’s leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world’s biopharmaceutical companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company’s Web site at http://www.kendle.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.
CONTACT: Investors, Patty Frank, +1-513-763-1992, or Media, Lori Dorer,+1-513-345-1685, both of Kendle International Inc.
